{"id":17876,"date":"2022-10-24T15:43:54","date_gmt":"2022-10-24T15:43:54","guid":{"rendered":"https:\/\/globalhealthintelligence.com\/?p=17876"},"modified":"2026-02-16T12:17:33","modified_gmt":"2026-02-16T18:17:33","slug":"nanomedicine-opens-the-door-to-tomorrows-health","status":"publish","type":"post","link":"https:\/\/globalhealthintelligence.com\/pt-br\/ghi-analysis\/nanomedicine-opens-the-door-to-tomorrows-health\/","title":{"rendered":"Nanomedicine Opens the Door to Tomorrow\u2019s Health"},"content":{"rendered":"\n<p>The health sector is constantly evolving, more so at a\ntime when emerging technologies such as nanomedicine are beginning to gain\nground. Advances in science have turned this leading-edge technology, created\nto prevent, control, and treat diseases, and improve our quality of life, into\na tangible reality. The application of nanotechnology to biomedicine\u2014by which\nwe mean handling materials on a nanometric scale\u2014has been put forward as a way\nof developing new systems of controlled drug delivery. The idea is based on\nusing nanostructures such as liposomes, dendrimers, fullerenes, or polymeric\nnanoparticles to move drugs into the damaged area, and after having recognized\nthe specific area affected, they release it in response to a stimulus. The use\nof these nanocarriers offers enormous benefits over conventional drug delivery\nmethods. Their size allows them to pass through biological and physiological\nbarriers that were previously inaccessible.<\/p>\n\n\n\n<p>Patients nowadays are able to make informed choices\nabout their health. Most prefer therapies with fewer side effects, which puts\nnanomedicine in a prime position. Drug delivery, therapy, diagnostics, and\nbiomaterials are some of the areas where nanomedicine has had the biggest\nimpact in the medical sector.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Nanomedicine as a health ally<\/h2>\n\n\n\n<p>Nanomedicine has significantly changed the health\nsector. Its main benefits include:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>More effective diagnostics<\/li><li>The opportunity to cure diseases\nfrom outside or within the body<\/li><li>Systems with more practical storage<\/li><li>Sensors that detect alterations in\nthe body<\/li><li>Lower costs in medical practices<\/li><li>Better drug dose management<\/li><li>The development of smart tissues<\/li><li>The development of non-polluting\nmaterials and energies<\/li><\/ul>\n\n\n\n<p>One common problem in the health sector is the loss of\ndrug efficacy over time. However, the deployment of nanomedicine through the\nuse of nanomaterials such as nanotubes or nanocapsules has made it possible to\novercome this issue by preserving the full functionality of enzymes and\nproteins to ensure they remain active.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Segmentation of the nanotechnology market<\/h2>\n\n\n\n<p>The\nmarket is segmented or classified on the basis of the following variables:<\/p>\n\n\n\n<p><strong>By product type<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Regenerative medicine<\/li><li>Therapeutic medicine<\/li><li>In vitro diagnostics<\/li><li>In vivo diagnostics <\/li><li>Vaccines<\/li><\/ul>\n\n\n\n<p><strong>By application<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Clinical oncology<\/li><li>Infectious diseases<\/li><li>Clinical cardiology<\/li><li>Orthopedics<\/li><li>Others<\/li><\/ul>\n\n\n\n<p><strong>By nanomolecule type<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Nanoparticles and quantum dots<\/li><li>Nanospheres<\/li><li>Nanotubes<\/li><li>Nanodevices<\/li><\/ul>\n\n\n\n<p>Latin\nAmerica has great opportunities and challenges with respect to nanomedicine.\nWhile governments have increased support and funding to drive this innovative\ntechnology in the region, so far it has been unable to thrive successfully\nbecause of the various challenges facing Latin America. Large growth in this\ntechnology is expected as a consequence of the increase in chronic diseases,\nsuch as diabetes, various types of cancer, liver disorders, etc.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How ready is Latin America for nanotechnology?<\/h2>\n\n\n\n<p>Is\nthere a door opening into Latin America? Are countries in the region ready to\ntackle nanomedicine? Although the technology is advancing quickly, and even at\na much faster pace than the health systems themselves, there has been an\nincrease in research-and-development investment in the region, which has\ncontributed to the growth of nanomedicine in Latin America.<\/p>\n\n\n\n<p>A\ngood example of this is the Argentine company PLAMIC, a microfluidics platform\nthat designs, manufactures, and characterizes chips or lab-on-a-chip systems,\nand has been developing state-of-the-art technology for nine years. The\ntechnology will enable greater precision in the development of nanomedicines through\nthe precise control of fluid movement, which in turn will allow for precise\nassembly of the molecules to build those medicines, reducing costs and\nimproving pharmaceutical quality.<\/p>\n\n\n\n<p>On\nthe other hand, factors such as long approval processes or the environmental\nrisks associated with new technologies limit their development, and despite\ngreat scientific advances, there is still no regulatory body in place to\npromote and protect nanomedicine.<\/p>\n\n\n\n<p>However, the outlook is encouraging. According to <a rel=\"noreferrer noopener\" aria-label=\"Market Data Forecast (opens in a new tab)\" href=\"https:\/\/www.marketdataforecast.com\/market-reports\/latin-america-nanomedicine-market\" target=\"_blank\">Market Data Forecast<\/a>, the nanomedicine market in Latin America is expected to grow at a 14.1% compound annual growth rate (CAGR) between 2021 and 2027 to reach a value of US$37.4 billion, which is nearly double its value in 2021: US$19.3 <a href=\"https:\/\/globalhealthintelligence.com\/es\/analisis-de-ghi-2\/la-explosion-de-la-tecnologia-medica-en-latinoamerica\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">billion<\/a>.<\/p>\n\n\n\n<p>The\nincreasing use of nanomaterials and the emergence of new technologies are\ndriving industry growth exponentially, representing new development\nopportunities. The scope of nanomedicine is broad and promises to provide\npreviously unimaginable solutions. It is an area of knowledge that needs to be expanded\nbecause of the potential it represents for patients and its possible range of\napplication in Latin America.<\/p>\n\n\n\n<p>Although Global Health Intelligence focuses mainly on topics related to hospital medical infrastructure, we are also dedicated to studying and following trends to gain a better understanding of the market. To learn more about the market intelligence solutions we offer for the medical device and equipment sector, visit our website at <a href=\"https:\/\/globalhealthintelligence.com\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">https:\/\/globalhealthintelligence.com\/<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The future has arrived and is now part of daily life, thanks to a range of<br \/>\n technological innovations<\/p>\n","protected":false},"author":13,"featured_media":17877,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32],"tags":[],"class_list":{"0":"post-17876","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ghi-analysis"},"_links":{"self":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/17876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/comments?post=17876"}],"version-history":[{"count":2,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/17876\/revisions"}],"predecessor-version":[{"id":29795,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/17876\/revisions\/29795"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/media\/17877"}],"wp:attachment":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/media?parent=17876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/categories?post=17876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/tags?post=17876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}